A detailed history of Avantax Advisory Services, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 331,936 shares of PFE stock, worth $8.48 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
331,936
Previous 308,754 7.51%
Holding current value
$8.48 Million
Previous $8.64 Million 11.21%
% of portfolio
0.06%
Previous 0.06%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $642,141 - $727,682
23,182 Added 7.51%
331,936 $9.61 Million
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $421,159 - $493,520
16,673 Added 5.71%
308,754 $8.64 Million
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $645,515 - $741,258
-24,933 Reduced 7.86%
292,081 $8.11 Million
Q4 2023

Feb 07, 2024

BUY
$26.13 - $33.94 $493,857 - $641,466
18,900 Added 6.34%
317,014 $9.13 Million
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $584,326 - $683,019
18,209 Added 6.51%
298,114 $9.89 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $108,468 - $125,495
3,003 Added 1.08%
279,905 $10.3 Million
Q1 2023

Apr 28, 2023

BUY
$39.39 - $51.28 $1.98 Million - $2.58 Million
50,267 Added 22.18%
276,902 $11.3 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $2.13 Million - $2.78 Million
-51,019 Reduced 18.38%
226,635 $11.6 Million
Q3 2022

Nov 01, 2022

BUY
$43.76 - $53.42 $703,179 - $858,405
16,069 Added 6.14%
277,654 $12.2 Million
Q2 2022

Aug 02, 2022

BUY
$46.53 - $55.17 $741,315 - $878,968
15,932 Added 6.49%
261,585 $13.7 Million
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $241,514 - $299,266
5,279 Added 2.2%
245,653 $12.7 Million
Q4 2021

Jan 24, 2022

BUY
$41.32 - $61.25 $354,690 - $525,770
8,584 Added 3.7%
240,374 $14.2 Million
Q3 2021

Oct 21, 2021

BUY
$39.25 - $50.42 $249,904 - $321,024
6,367 Added 2.82%
231,790 $9.97 Million
Q2 2021

Jul 29, 2021

BUY
$35.91 - $40.68 $491,105 - $556,339
13,676 Added 6.46%
225,423 $8.83 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $40,522 - $45,701
1,210 Added 0.57%
211,747 $7.66 Million
Q4 2020

Jan 22, 2021

SELL
$33.47 - $42.56 $6.43 Million - $8.18 Million
-192,251 Reduced 47.73%
210,537 $7.75 Million
Q3 2020

Oct 14, 2020

BUY
$31.75 - $37.25 $8.23 Million - $9.65 Million
259,108 Added 180.34%
402,788 $14.8 Million
Q2 2020

Aug 06, 2020

BUY
$30.12 - $36.54 $31,686 - $38,440
1,052 Added 0.74%
143,680 $4.7 Million
Q1 2020

Apr 30, 2020

SELL
$27.03 - $38.62 $433,344 - $619,155
-16,032 Reduced 10.1%
142,628 $4.66 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $1.03 Million - $1.17 Million
31,217 Added 24.49%
158,660 $6.22 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $229,411 - $297,479
7,061 Added 5.87%
127,443 $4.58 Million
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $494,311 - $554,997
13,367 Added 12.49%
120,382 $5.22 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $385,800 - $423,865
10,288 Added 10.64%
107,015 $4.55 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $3.72 Million - $4.24 Million
96,727 New
96,727 $4.22 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $143B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.